Pulse Explorer nav.journalClub Débats Tendances Chercheurs

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

Alzheimer's disease: The right drug, the right time | Synapse

December 13, 2018

View Full Paper

Maladie d'Alzheimer : Le bon médicament, au bon moment

Key Points

Key points are not available for this paper at this time.

Abstract

Les leçons des essais cliniques échoués peuvent améliorer le développement des thérapies modifiant la maladie d'Alzheimer.

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Golde et al. (Thu,) ont étudié cette question.

synapsesocial.com/papers/6a1718a683b2be9fec6bbf09 https://doi.org/https://doi.org/10.1126/science.aau0437

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers2016 · 1,887 citations
2Alzheimer’s disease drug-development pipeline: few candidates, frequent failures2014 · 1,750 citations
3Cometary dust under the microscope2016 · 4 citations
4Inhibition of Leukotriene B<sub>4</sub> synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate1990 · 68 citations
5Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse2008 · 66 citations